Newborn and Infant Nursing Reviews
Volume 6, Issue 3 , Pages 163-164 , September 2006

Patent Ductus Arteriosus and B-Type Natriuretic Peptide in the Premature Infant: A Trial Analysis

  • Holly Mincey, RN, BSN

      Affiliations

    • Corresponding Author InformationAddress correspondences to Holly Mincey, RN, BSN, 8223 Alpine Aster Court, Liberty Township, OH 45044.

References 

  1. Struthers AD . Ten years of natriuretic peptide research: a new dawn for their diagnostic and therapeutic use?. BMJ. 1994;308:1615–1619
  2. National Institute of Child Health and Human Development, Neonatal Research Network Generic Database Study, 2003-2004. Neonatal Research Network generic data base survey of morbidity and mortality in very low birth weight infants 401-1500 gms (2004).
  3. Koch A , Singer H . Normal values of B-type natriuretic peptide in infants, children and adolescents. Heart. 2003;89:875–878
  4. Flynn P , Da Graca R , Auld P , Nesin M , Kleinman C . The use of bedside assay for plasma B-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr. 2005;147:38–42

PII: S1527-3369(06)00070-5

doi: 10.1053/j.nainr.2006.06.001

Newborn and Infant Nursing Reviews
Volume 6, Issue 3 , Pages 163-164 , September 2006

Article Tools